Evan Leitner has represented high growth companies and investment banks on capital markets and corporate transactions, including initial and follow-on public equity offerings and high-yield, investment-grade and convertible debt offerings. Evan also counsels publicly held companies with respect to corporate governance, SEC reporting and securities law compliance.

Download full bio 


  • Avidity Biosciences – $238 Million Follow-on Offering 

  • Aura Biosciences – $86.7 Million Follow-on Offering 

  • Zentalis Pharmaceuticals – $200 Million Follow-On Offering 

  • The Clorox Company – $1.1 Billion Unsecured Senior Notes Offering 

  • argenx – $805 Million Follow-On Offering 

  • View all


  • New York University School of Law
    JD, 2015

  • Yale University
    BA, 2009

Admissions & Credentials

New York

New Jersey